According to AlphaMoat, in October 2026 Vilya (vilya.ai) received 1,041 monthly visits (-78% MoM) — ranked #16,308 of 17,609 AI websites with traffic data, and #2,833 of 3,112 in Industry Services.
Vilya uses computation-driven drug design to create macrocyclic molecules that do not exist in nature—combining the selectivity of biologics with the convenience of oral pills—to tackle previously hard-to-treat diseases. The company grew out of Nobel Prize-level research from the Institute for Protein Design, with scientific founder David Baker winning the 2024 Nobel Prize in Chemistry.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-07 | - | — |
| 2026-08 | 1.1K | — |
| 2026-09 | 4.7K | +319.4% |
| 2026-10 | 1.0K | -78.0% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, Vilya (vilya.ai) received 1,041 visits (about 1.0K) in October 2026 (-78% month over month), ranking #16,308 of 17,609 AI websites with traffic data, and #2833 in Industry Services.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.